Cargando…
Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus
Staphylococcus aureus is a facultative intracellular pathogen that invades and replicates within many types of human cells. S. aureus has shown to rapidly overcome traditional antibiotherapy by developing multidrug resistance. Furthermore, intracellular S. aureus is protected from the last-resort an...
Autores principales: | Bravo-Santano, Natalia, Behrends, Volker, Letek, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963206/ https://www.ncbi.nlm.nih.gov/pubmed/31795127 http://dx.doi.org/10.3390/antibiotics8040241 |
Ejemplares similares
-
Identification of novel targets for host-directed therapeutics against intracellular Staphylococcus aureus
por: Bravo-Santano, Natalia, et al.
Publicado: (2019) -
Intracellular Staphylococcus aureus Modulates Host Central Carbon Metabolism To Activate Autophagy
por: Bravo-Santano, Natalia, et al.
Publicado: (2018) -
Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus
por: Bravo-Santano, Natalia, et al.
Publicado: (2019) -
Intracellular Staphylococcus aureus Elicits the Production of Host Very Long-Chain Saturated Fatty Acids with Antimicrobial Activity
por: Bravo-Santano, Natalia, et al.
Publicado: (2019) -
Editorial: Novel approaches to prevent and treat intracellular bacterial infections
por: Behrends, Volker, et al.
Publicado: (2023)